Marion Wealth Management’s Quest Diagnostics DGX Stock Holding History

Marion Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.05M	Buy	14,390 +447	+3%	+$87.7K	0.62%	39
2026 Q1	$2.73M	Buy	13,943 +443	+3%	+$86.1K	0.61%	41
2025 Q4	$2.44M	Buy	13,500 +1,082	+9%	+$197K	0.54%	47
2025 Q3	$2.37M	Buy	12,418 +334	+3%	+$59.3K	0.56%	45
2025 Q2	$2.17M	Buy	+12,084	New	+$2.1M	0.54%	46

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Marion Wealth Management's DGX Position: Q2 2026 in Review

Marion Wealth Management increased its Quest Diagnostics (DGX) stake by 3.2% in Q2 2026, buying an estimated $87.7K and bringing the position to 14,390 shares worth $3.05M. The position accounts for 0.62% of the portfolio, ranked #39.

Marion Wealth Management first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Marion Wealth Management held 14,390 shares of Quest Diagnostics worth $3.05M as of Q2 2026.
Marion Wealth Management bought 447 Quest Diagnostics shares in Q2 2026, an estimated $87.7K.
Quest Diagnostics made up 0.62% of Marion Wealth Management's portfolio in Q2 2026, its #39 holding.
Marion Wealth Management first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Marion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.